Special typesGLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonistsplay a vital role in controlling appetite, managing blood sugar, and metabolizing fats
In a clinical program, linagliptin demonstrated a significant reduction in HbA1c from baseline compared to placebo at 24 weeks
Generally, the side effects associated with these medications are mild, transient, and ease after the body adapts to the medication
The potential risks of taking these products are certainly real, but this feels like something that should be taken up with individuals and their doctors (as with any drug pls!) rather than litigated via a Super Bowl ad
Thereafter, medium was replaced by new medium with or without ghrelin at concentrations of 10 nM, 100 nM, and 1 M and cells were incubated for 24 h